Medication info
Truempah Tablet 10 mg (Empagliflozin)

Truempah Tablet 10 mg (Empagliflozin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›10mg / 1 tablet
Manufacturer / importer
Boryung Pharmaceutical Co., Ltd.
Appearance
Pale yellow, round film-coated tablet
Packaging
Domestic - 30 tablets/PTP [(10 tablets/PTP × 3)]
Approval status
Active

MFDS item code 202105615 · Approved 2021.07.29 · Insurance code 641908600

Summary

Main use
Treatment of type 2 diabetes mellitus, chronic heart failure, and chronic kidney disease
Who takes it
Adults
Adult dose
Type 2 diabetes mellitus The recommended dose of this medicine is 10 mg once daily, either as monotherapy or as add-on therapy with other glucose-lowering agents, such as insulin. If 10 mg once daily is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. Chronic heart failure The recommended dose of this medicine is 10 mg once daily. Chronic kidney disease The recommended dose of this medicine is 10 mg once daily. This medicine should be administered in combination with other standard treatments for chronic kidney disease. Type 2 diabetes mellitus, chronic heart failure, and chronic kidney disease When this medicine is used with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3, Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose on the same day. Special populations • Patients with renal impairment Type 2 diabetes mellitus This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. This medicine should not be used in patients with end-stage renal disease (ESRD) or receiving dialysis, as efficacy is not expected. Chronic heart failure This medicine should not be used in patients with an estimated glomerular filtration rate (eGFR) below 20 ml/min/1.73m2. Chronic kidney disease This medicine may be used regardless of renal function. However, because experience is limited, initiation of treatment is not recommended in patients with an estimated glomerular filtration rate (eGFR) below 20 ml/min/1.73m2. • Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older (see Precautions for Use, section 4, General Precautions).

Ingredients

Manufacturer
Boryung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus, chronic heart failure, and chronic kidney disease

  • Type 2 diabetes
  • poor blood sugar control
  • chronic heart failure
  • cardiovascular disease
  • chronic kidney disease
View approved original text

This drug is used in conjunction with diet and exercise to help control blood sugar in patients with type 2 diabetes. It also helps manage the risk of cardiovascular events in diabetic patients with cardiovascular disease. For patients with chronic heart failure, it is administered in combination with other treatments to reduce the risk of heart failure exacerbation or cardiovascular death. In patients with chronic kidney disease, it is effective in reducing the risk of kidney function deterioration and cardiovascular death. In summary, this drug is comprehensively used to manage cardiovascular diseases, chronic heart failure, and kidney disease associated with diabetes, contributing to the improvement of patient health.

How to take

Adult dose

Type 2 diabetes mellitus The recommended dose of this medicine is 10 mg once daily, either as monotherapy or as add-on therapy with other glucose-lowering agents, such as insulin. If 10 mg once daily is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. Chronic heart failure The recommended dose of this medicine is 10 mg once daily. Chronic kidney disease The recommended dose of this medicine is 10 mg once daily. This medicine should be administered in combination with other standard treatments for chronic kidney disease. Type 2 diabetes mellitus, chronic heart failure, and chronic kidney disease When this medicine is used with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3, Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose on the same day. Special populations • Patients with renal impairment Type 2 diabetes mellitus This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. This medicine should not be used in patients with end-stage renal disease (ESRD) or receiving dialysis, as efficacy is not expected. Chronic heart failure This medicine should not be used in patients with an estimated glomerular filtration rate (eGFR) below 20 ml/min/1.73m2. Chronic kidney disease This medicine may be used regardless of renal function. However, because experience is limited, initiation of treatment is not recommended in patients with an estimated glomerular filtration rate (eGFR) below 20 ml/min/1.73m2. • Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older (see Precautions for Use, section 4, General Precautions).

Precautions

This drug should not be used by individuals who are allergic to the active substance or constituents, type 1 diabetes patients, those with diabetic ketoacidosis, and individuals with genetic issues such as lactose intolerance or galactose intolerance. Patients with impaired kidney function should have their renal function regularly monitored while using this drug, and it is not recommended for patients with severe renal impairment or those on dialysis. When taken with medications such as insulin or sulfonylureas, there is a risk of hypoglycemia, so blood sugar levels should be closely monitored during treatment and insulin dosage adjusted as necessary. During treatment, side effects such as hypoglycemia, urinary tract infections, genital infections, increased urination, and reduced fluid volume may occur, and if symptoms develop, medical consultation should be sought immediately. Particularly in diabetic patients, rare life-threatening ketoacidosis may occur, so if symptoms such as vomiting, abdominal pain, or difficulty breathing develop, immediate treatment should be sought, and these symptoms should be closely monitored during treatment. Elderly patients or those at risk of fluid volume loss should be cautious of dehydration and hypotension, and may need to temporarily discontinue this drug if necessary. This drug can cause liver damage, so any symptoms indicating liver dysfunction should be reported to a healthcare provider immediately. Attention is needed while driving or operating machinery due to the risk of hypoglycemia, especially when taken with insulin or sulfonylureas. Women who are pregnant or planning to become pregnant should avoid using this drug, and breastfeeding should be discontinued during treatment. Children and adolescents (under 18 years) should not use this drug, as its safety and efficacy have not been established.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • constipation
  • pruritus
  • rash
  • urticaria
  • angioedema
  • decreased fluid volume
  • increased urination
  • urinary difficulties
Show 210 more
  • interstitial nephritis
  • thirst
  • elevated serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • vulvar lichen planus
  • vulvitis
  • balanitis
  • other genital infections
  • urinary tract infection
  • perineal necrosis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • gastrointestinal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • adnexal-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureterolithiasis
  • acute kidney injury
  • cervicitis
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • proliferative diabetic retinopathy
  • limb injury
  • road traffic accident
  • splenic injury
  • sternal fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the ampullary region
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic adenocarcinoma
  • colorectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • unstable angina
  • epigastric pain
  • dental caries
  • erosive gastritis
  • abdominal discomfort
  • dry mouth
  • gastroesophageal reflux disease
  • abdominal distension
  • rectal bleeding
  • chronic gastritis
  • enteritis
  • meteorism
  • gastric polyps
  • gingival edema
  • passage of blood in stool
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • toothache
  • dyspepsia
  • upper respiratory infection
  • bronchitis
  • chronic sinusitis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • nasopharyngitis
  • positional vertigo
  • sensory loss
  • abnormal perception
  • amnesia
  • diabetic neuropathy
  • facial paralysis
  • memory disturbances
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • drowsiness
  • fatigue
  • peripheral edema
  • facial edema
  • fever
  • facial swelling
  • chills
  • strange sensation
  • edema
  • pain
  • tenderness at the puncture site
  • weight gain
  • abnormal ECG
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urine red blood cells
  • hematuria
  • overactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • urinary abnormalities
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • dysgeusia
  • hyperlipidemia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • musculoskeletal pain
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • eye discomfort
  • conjunctival hyperemia
  • eyelid edema
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • residual sputum
  • skin laceration
  • bruise
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliolumbar ligament syndrome
  • open globe injury
  • pelvic fracture
  • anxiety
  • depression
  • sleep disorder
  • otalgia
  • positional vertigo
  • dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • vulvar pruritus
  • genital pruritus
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to prevent air or moisture ingress. It is recommended to store at room temperature, specifically between 1°C and 30°C, to maintain its efficacy and ensure safe use.

Appearance and packaging

Appearance

Pale yellow, round film-coated tablet

Package unit

Domestic - 30 tablets/PTP [(10 tablets/PTP × 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.